Trial intelligence / Profile preview

Tenofovir alafenamide in late pregnancy for prevention of hepatitis B mother-to-child transmission

ChiCTR1900022800Phase 4Recruiting

Sponsor
Beijing YouAn Hospital
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tenofovir alafenamide, sponsored by Beijing YouAn Hospital. Started Apr 2019; status: recruiting.

02

Drugs

tenofovir alafenamide

Beyond the preview

Go deeper on ChiCTR1900022800.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900022800.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call